Preparation and in vitro/in vivo evaluation of luteinizing hormone releasing hormone (LHRH)-loaded polyhedral and spherical/tubular niosomes

Journal of Pharmaceutical Sciences

Volumn 88, Issue 1, 1999, Pages 34-38

  Arunothayanun, Parinya ^a   Turton, John A ^a   Uchegbu, Ijeoma F ^a,b   Florence, Alexander T ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ETHER DERIVATIVE; GONADORELIN; NIOSOME; NONIONIC SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG DELIVERY SYSTEM; ELECTRON MICROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDRATION; MALE; NONHUMAN; RAT; REHYDRATION; SYNTHESIS;

EID: 0032904159     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980286u     Document Type: Article

References (20)

1. Florence, A. T. Nonionic surfactant vesicles: preparation and characterization. In: Liposome Technology, Gregoriadis, G., Ed.; CRC: Boca Raton, FL, 1993; pp 157-176.
2. Uchegbu, I. F.; Florence, A. T. Nonionic surfactant vesicles (Niosomes): physical and pharmaceutical chemistry. Adv. Colloid Interface Sci. 1995, 58, 1-55.
3. Bernard, M.-S.; Arunothayanun, P.; Uchegbu, I. F.; Florence, A. T. Rheological and morphological study of polyhedral and spherical/tubular niosomes. 3rd UKCRS Symposium on Controlled Drug Delivery, University of Manchester, UK, January 1997; Abstract.
4. Arunothayanun, P.; Uchegbu, I. F.; Florence, A. T. Properties of polyhedral niosomes. Pharm. Res. 1996, 13, Suppl., s-159.
5. th Intl. Symp. Control. Relat. Bioact. Mater., 1997; pp 977-978.
6. Uchegbu, I. F.; Schätzlein, A.; Vanlerberghe, G.; Morgatini, N.; Florence, A. T. Polyhedral nonionic surfactant vesicles. J. Pharm. Pharmacol. 1997, 49, 606-610.
7. 2) nonionic surfactant, cholesterol and cholesteryl poly-24-oxyethylene ether: vesicles, tubules, discomes and micelles. S. T. P. Pharma Sci. 1996, 6, 33-43.
8. Surewicz, W. K.; Epand, R. M. Role of peptide structure in lipid peptide interactions-high-sensitivity differential scanning calorimetry and electron-spin resonance studies of the structural-properties of dimyristoylphosphatidylcholine membranes interacting with pentagastrin-related pentapeptides. Biochemistry 1985, 24, 3135-3144.
9. Schäfer, H.; Schmidt, W.; Lachmann, U. Preparation and properties of GnRH-loaded multilamellar liposomes. Pharmazie 1987, 42, 674-677.
10. Mayer, L. D.; Madden, T. D.; Bally, M. B.; Cullis, P. R. pH Gradient-Mediated Drug Entrapment in Liposomes. In: Liposome Technology: Entrapment of Drugs and Other Materials, 2nd ed.; Gregoriadis, G., Ed.; CRC: Boca Raton, FL, 1992; pp 27-44.
11. Lasic, D. D.; Frederik, P. M.; Stuart, M. C. A.; Barenholz, Y.; McIntosh, T. J. Gelation of liposome interior. A novel method for drug encapsulation. FEBS Lett. 1992, 312, 255-258.
12. Madden, T. D.; Harrigan, P. R.; Tai, L. C. L.; Bally, M. B.; Mayer, L. D.; Redelmeier, T. E.; Loughrey, H. C.; Tilcock, C. P. S.; Reinish, L. W.; Cullis, P. R. The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey. Chem. Phys. Lipids 1990, 53, 37-46.
13. Guzmán, M.; Selles, E.; Abérturas, M. C. Effect of human plasma on the stability of large multilamellar liposomes with digitoxin. Drug Dev. Ind. Pharm. 1989, 15, 387-399.
14. Storm, G.; Van Bloois, L.; Steerenberg, P. A.; Van Etten, E.; De Groot, G.; Crommelin, D. J. A. Liposome encapsulation of doxorubicin: pharmaceutical and therapeutic aspects. J. Controlled. Release. 1989, 9, 215-229.
15. Arrowsmith, M.; Hadgraft, J.; Kellaway, I. W. The stability of a prodrug, liposome and a prodrug-liposome complex in simulated biological conditions. Int. J. Pharm. 1983, 17, 91-98.
16. Zuidema, J.; Kadir, F.; Titulaer, H. A. C.; Oussoren, C. Release and absorption rates of intramuscularly and subcutaneously injected pharmaceuticals (II). Int. J. Pharm. 1994, 105, 189-207.
17. Jackson, A. J. The effect of route of administration on the disposition of inulin encapsulated in multilamellar vesicles of defined particle size. Res. Comm. Chem. Path. Pharm. 1980, 27, 293-304.
18. Richards, R. L.; Hailey, J. R.; Egan, J. E.; Gordon, D. M.; Johnson, A. J.; Alving, C. R.; Wassef, N. M. Intramuscular fate and local effects of liposomes as carriers for drugs and vaccines. In Liposomes in Biomedical Applications, Shek, P. N., Ed.; Harwood Academic: Chur Switzerland, 1995; pp 167-178.
19. Schäfer, H.; Schmidt, W.; Berger, H.; Bergfeld, J. Pharmacokinetics of gonadotropin-releasing hormone and stimulation of luteinizing hormone secretion after single dose administration of GnRH incorporated into liposomes. Pharmazie 1987, 42, 689-693.
20. Powell, M. F.; Sanders, L. M.; Rogerson, A.; Si, V. Parenteral peptide formulations: chemical and physical properties of native luteinizing hormone-releasing hormone (LHRH) and hydrophobic analogues in aqueous solutions. Pharm. Res. 1991, 8, 1258-1263.